Rathbones Group’s NanoViricides NNVC Stock Holding History

Rathbones Group’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,413	Closed	-$7K	–	338
2019 Q2	$7K	Hold	1,413	–	–	﹤0.01%	315
2019 Q1	$8K	Hold	1,413	–	–	﹤0.01%	313
2018 Q4	$6K	Hold	1,413	–	–	﹤0.01%	315
2018 Q3	$10K	Hold	1,413	–	–	﹤0.01%	302
2018 Q2	$12K	Hold	1,413	–	–	﹤0.01%	304
2018 Q1	$23K	Hold	1,413	–	–	﹤0.01%	308
2017 Q4	$25K	Hold	1,413	–	–	﹤0.01%	316
2017 Q3	$32K	Hold	1,413	–	–	﹤0.01%	309
2017 Q2	$38K	Hold	1,413	–	–	﹤0.01%	309
2017 Q1	$32K	Hold	1,413	–	–	﹤0.01%	318
2016 Q4	$30K	Hold	1,413	–	–	﹤0.01%	309
2016 Q3	$48K	Hold	1,413	–	–	﹤0.01%	307
2016 Q2	$45K	Hold	1,413	–	–	﹤0.01%	300
2016 Q1	$62K	Hold	1,413	–	–	﹤0.01%	294
2015 Q4	$34K	Hold	1,413	–	–	﹤0.01%	290
2015 Q3	$34K	Hold	1,413	–	–	﹤0.01%	302
2015 Q2	$49K	Hold	1,413	–	–	﹤0.01%	313
2015 Q1	$64K	Hold	1,413	–	–	﹤0.01%	315
2014 Q4	$77K	Hold	1,413	–	–	0.01%	314
2014 Q3	$85K	Hold	1,413	–	–	0.01%	293
2014 Q2	$119K	Hold	1,413	–	–	0.01%	275
2014 Q1	$90K	Buy	+1,413	New	+$121K	0.01%	273

Other funds holding NNVC

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Rathbones Group's NNVC Position: Q3 2019 in Review

Rathbones Group sold out of NanoViricides (NNVC) in Q3 2019, closing a stake of 1,413 shares — an estimated $7K sold.

Rathbones Group first reported a position in NNVC in Q1 2014 and held it in 22 quarters. The position peaked at $119K in Q2 2014. 17 funds tracked by Wall St. Rank hold NNVC as of Q3 2019.

Rathbones Group reported no remaining NanoViricides position as of Q3 2019 after selling out during the quarter.
Rathbones Group sold 1,413 NanoViricides shares in Q3 2019, an estimated $7K.
Rathbones Group first reported a position in NanoViricides in Q1 2014 and held it in 22 quarters.
Rathbones Group's NanoViricides position peaked at $119K in Q2 2014.
17 funds tracked by Wall St. Rank held NanoViricides as of Q3 2019.

Based on Rathbones Group's 13F filing for Q3 2019, filed 13 Nov 2019.